Yi‐Te Lee

1.4k total citations
26 papers, 531 citations indexed

About

Yi‐Te Lee is a scholar working on Hepatology, Epidemiology and Oncology. According to data from OpenAlex, Yi‐Te Lee has authored 26 papers receiving a total of 531 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Hepatology, 11 papers in Epidemiology and 7 papers in Oncology. Recurrent topics in Yi‐Te Lee's work include Hepatocellular Carcinoma Treatment and Prognosis (13 papers), Liver Disease Diagnosis and Treatment (10 papers) and Cancer Genomics and Diagnostics (5 papers). Yi‐Te Lee is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (13 papers), Liver Disease Diagnosis and Treatment (10 papers) and Cancer Genomics and Diagnostics (5 papers). Yi‐Te Lee collaborates with scholars based in United States, Taiwan and China. Yi‐Te Lee's co-authors include Ju Dong Yang, Hsian‐Rong Tseng, Vatche G. Agopian, Yazhen Zhu, Jasmine J. Wang, Amit G. Singal, Mazen Noureddin, Naoto Fujiwara, Yujin Hoshida and Sungyong You and has published in prestigious journals such as Journal of Clinical Oncology, Hepatology and JNCI Journal of the National Cancer Institute.

In The Last Decade

Yi‐Te Lee

25 papers receiving 527 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yi‐Te Lee United States 12 262 193 156 138 131 26 531
Dinglan Zuo China 14 187 0.7× 130 0.7× 100 0.6× 193 1.4× 249 1.9× 25 534
Zebin Chen China 12 259 1.0× 77 0.4× 118 0.8× 81 0.6× 99 0.8× 28 485
Sirui Fu China 14 231 0.9× 100 0.5× 95 0.6× 158 1.1× 191 1.5× 29 530
Laura Venerandi Italy 9 295 1.1× 190 1.0× 83 0.5× 140 1.0× 138 1.1× 16 578
Min Du China 13 177 0.7× 65 0.3× 146 0.9× 151 1.1× 111 0.8× 37 550
Licong Liang China 9 205 0.8× 99 0.5× 112 0.7× 84 0.6× 83 0.6× 21 419
Wenjie Hu China 14 188 0.7× 117 0.6× 178 1.1× 108 0.8× 71 0.5× 32 496
Christine Dela Cruz United States 5 363 1.4× 131 0.7× 153 1.0× 85 0.6× 63 0.5× 14 477
Nobuhiro Tsuchiya Japan 10 196 0.7× 149 0.8× 236 1.5× 202 1.5× 308 2.4× 28 769
Imane El Dika United States 13 178 0.7× 69 0.4× 214 1.4× 145 1.1× 207 1.6× 30 573

Countries citing papers authored by Yi‐Te Lee

Since Specialization
Citations

This map shows the geographic impact of Yi‐Te Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yi‐Te Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yi‐Te Lee more than expected).

Fields of papers citing papers by Yi‐Te Lee

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yi‐Te Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yi‐Te Lee. The network helps show where Yi‐Te Lee may publish in the future.

Co-authorship network of co-authors of Yi‐Te Lee

This figure shows the co-authorship network connecting the top 25 collaborators of Yi‐Te Lee. A scholar is included among the top collaborators of Yi‐Te Lee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yi‐Te Lee. Yi‐Te Lee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lee, Yi‐Te, Jasmine J. Wang, Pojsakorn Danpanichkul, et al.. (2025). Recent Trends of Incidence, Mortality, Treatment, and Overall Survival of Hepatocellular Carcinoma in the United States. Clinical Gastroenterology and Hepatology.
2.
Park, Jae‐Ho, Yi‐Te Lee, Vatche G. Agopian, et al.. (2024). Liquid biopsy in hepatocellular carcinoma: Challenges, advances, and clinical implications. Clinical and Molecular Hepatology. 31(Suppl). S255–S284. 7 indexed citations
3.
Lee, Yi‐Te, Yee Hui Yeo, Michael Luu, et al.. (2024). Impact of the Early COVID-19 Pandemic on Incidence and Outcomes of Hepatocellular Carcinoma in the United States. Clinical and Translational Gastroenterology. 15(7). e00723–e00723. 3 indexed citations
4.
Karim, Mohammad A., Amit G. Singal, Hye‐Chung Kum, et al.. (2023). Prediagnostic CT or MRI Utilization and Outcomes in Hepatocellular Carcinoma: SEER-Medicare Database Analysis. Cancer Research Communications. 3(5). 874–883. 4 indexed citations
5.
Lee, Yi‐Te, Yu-Ting Huang, Shao-Pin Chiu, et al.. (2023). Determining the Electron Scattering from Interfacial Coulomb Scatterers in Two-Dimensional Transistors. ACS Applied Materials & Interfaces. 16(1). 1066–1073. 2 indexed citations
6.
Lee, Yi‐Te, Mohammad A. Karim, Hye‐Chung Kum, et al.. (2023). Factors associated with unrecognized cirrhosis in patients with hepatocellular carcinoma. Clinical and Molecular Hepatology. 29(2). 453–464. 4 indexed citations
7.
Karim, Mohammad A., Amit G. Singal, Hye‐Chung Kum, et al.. (2022). Clinical Characteristics and Outcomes of Nonalcoholic Fatty Liver Disease–Associated Hepatocellular Carcinoma in the United States. Clinical Gastroenterology and Hepatology. 21(3). 670–680.e18. 44 indexed citations
8.
Lee, Yi‐Te, Naoto Fujiwara, Ju Dong Yang, & Yujin Hoshida. (2022). Risk stratification and early detection biomarkers for precision HCC screening. Hepatology. 78(1). 319–362. 66 indexed citations
9.
Ahn, Joseph, Yi‐Te Lee, Vatche G. Agopian, et al.. (2022). Hepatocellular carcinoma surveillance: current practice and future directions. Hepatoma Research. 8. 35 indexed citations
10.
Sun, Na, Yi‐Te Lee, Minhyung Kim, et al.. (2022). An extracellular vesicle-based assay for noninvasive detection of metastases and monitoring prostate cancer.. Journal of Clinical Oncology. 40(16_suppl). e17004–e17004. 1 indexed citations
11.
Sun, Na, Yi‐Te Lee, Minhyung Kim, et al.. (2022). Extracellular vesicle-based assay for detecting metastases and dynamic monitoring of prostate cancer.. Journal of Clinical Oncology. 40(6_suppl). 182–182. 1 indexed citations
12.
Lee, Yi‐Te, Jasmine J. Wang, Michael Luu, et al.. (2021). State‐Level HCC Incidence and Association With Obesity and Physical Activity in the United States. Hepatology. 74(3). 1384–1394. 27 indexed citations
13.
Lee, Yi‐Te, Jasmine J. Wang, Yazhen Zhu, et al.. (2021). Diagnostic Criteria and LI‐RADS for Hepatocellular Carcinoma. Clinical Liver Disease. 17(6). 409–413. 21 indexed citations
14.
15.
Lee, Yi‐Te, Jasmine J. Wang, Michael Luu, et al.. (2021). Comparison of Clinical Features and Outcomes Between Intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma in the United States. Hepatology. 74(5). 2622–2632. 46 indexed citations
16.
Lee, Yi‐Te, Benjamin V. Tran, Jasmine J. Wang, et al.. (2021). The Role of Extracellular Vesicles in Disease Progression and Detection of Hepatocellular Carcinoma. Cancers. 13(12). 3076–3076. 41 indexed citations
17.
Teng, Pai‐Chi, Yu Jen Jan, Jie‐Fu Chen, et al.. (2020). Prostate cancer CTC-RNA Assay: A new method for contemporary genomics and precision medicine via liquid biopsy.. Journal of Clinical Oncology. 38(6_suppl). 170–170. 1 indexed citations
18.
Wang, Jing, Na Sun, Yi‐Te Lee, et al.. (2020). A circulating tumor cell-based digital assay for the detection of EGFR T790M mutation in advanced non-small cell lung cancer. Journal of Materials Chemistry B. 8(26). 5636–5644. 16 indexed citations
19.
Winograd, Paul, Shuang Hou, Colin M. Court, et al.. (2020). Hepatocellular Carcinoma–Circulating Tumor Cells Expressing PD‐L1 Are Prognostic and Potentially Associated With Response to Checkpoint Inhibitors. Hepatology Communications. 4(10). 1527–1540. 82 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dinglan Zuo Breakdown of academic impact, for papers by Zebin Chen Breakdown of academic impact, for papers by Sirui Fu Breakdown of academic impact, for papers by Laura Venerandi Breakdown of academic impact, for papers by Min Du Breakdown of academic impact, for papers by Licong Liang Breakdown of academic impact, for papers by Wenjie Hu Breakdown of academic impact, for papers by Christine Dela Cruz Breakdown of academic impact, for papers by Nobuhiro Tsuchiya Breakdown of academic impact, for papers by Imane El Dika
Rankless by CCL
2026